The focus of their [AIDS & public-health activists] concern is Washington's continued refusal to permit U.S. aid money to be used to buy life-preserving generic anti-retroviral (ARV) drugs manufactured in developing countries, such as India, Thailand, and Brazil...They also oppose the Bush administration's demand in recent negotiations for new trade agreements with poor countries, including Thailand and the countries of Central America, which they agree not to produce or import generic versions of new drugs developed by U.S. drug manufacturers for at least five years from the date that they first come to market.